BioCentury
ARTICLE | Product Development

Buy-in from high-income nations enables COVAX to secure COVID-19 vaccines for wealthy, lower income countries alike

September 22, 2020 11:50 PM UTC

The international community, minus the U.S. and China, have pledged support for an initiative that seeks to ensure global equitable distribution of COVID-19 vaccines.

The COVID-19 Vaccine Global Access (COVAX) aims to have 2 billion doses — for candidates with a prime-boost regimen, enough for 1 billion people — of safe and efficacious vaccines available by YE21...